ConductScience.org, home
THRB: thyroid hormone receptor beta
API referenceFor AI assistants

Gene · 7068

Papers3,032

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

21 to 40 of 3,032

Download this page as JSON
TitleJournalYearPMIDFound bySource
Exercise-Induced Hepatic Mitochondrial Reprogramming Across Muscle-Gut-Thyroid Axes in MASLD/MASH.Int J Mol Sci202642511461PubTator, text miningPubMed
Resistance to Thyroid Hormone Due to a Missense Heterozygous Mutation in the THR-β Gene: A Challenging Diagnosis.AACE Endocrinol Diabetes202642491547PubTator, text miningPubMed
The Potential Role of THR-β Agonizts in Reversing Liver Fibrosis and Cirrhosis Across Etiologies: Toward a Pan-Antifibrotic Therapy?J Clin Gastroenterol202642447394PubTator, text miningPubMed
Drug Development for MASH-Related Compensated Cirrhosis: Past, Present and Future.Liver Int202642438128PubTator, text miningPubMed
Thyroid-Liver Axis: Mechanistic Insights and Clinical Implications.Cureus202642437256PubTator, text miningPubMed
Pharmacological Therapy for Metabolic Dysfunction-Associated Steatotic Liver Disease in a New Era for Obesity and Metabolic Medicine: A State-of-the-Art Review.J Obes Metab Syndr202642421259PubTator, text miningPubMed
Identification and enrichment of human retinal organoid-derived red/green cone-competent precursors with enhanced axon dynamics.Stem Cell Res Ther202642401922PubTator, text miningPubMed
Adaptive evolution at thyroid hormone, insulin and glycerolipid pathways improved energy metabolism in high-latitude Eurasian populations.Commun Biol202642337340PubTator, text miningPubMed
When fatty liver fuels kidney cancer: the THRB connection.Hum Cell202642337130PubTator, text miningPubMed
Updating the MASH pharmacotherapy landscape: a network meta-analysis incorporating SGLT2 inhibitors and emerging combination therapies.Front Endocrinol (Lausanne)202642325618PubTator, text miningPubMed
Clinical and laboratory characteristics of pediatric patients diagnosed with thyroid hormone resistance: A single-center experience.Endocrine202642319533PubTator, text miningPubMed
Enhancing future liver remnant hypertrophy: innovative preoperative strategies and emerging technologies.Transl Gastroenterol Hepatol202642291162PubTator, text miningPubMed
Emerging pharmacotherapies for androgenetic alopecia.Expert Opin Pharmacother202642290527PubTator, text miningPubMed
Protease-activated receptor 1 as an endogenous model of peptidergic Gαq-Gα12-biased G protein signaling.Front Mol Biosci202642267118PubTator, text miningPubMed
Pharmacokinetics, mass balance and metabolic profiling of resmetirom in healthy subjects and nonclinical metabolism and disposition.Xenobiotica202642265836PubTator, text miningPubMed
Thyroid-Liver Axis: The Role of Thyroid Dysfunction in the Pathogenesis and Progression of MASLD: A Comprehensive Review.Liver Int202642246700PubTator, text miningPubMed
The immunometabolic mechanisms and therapeutic targets of metabolic dysfunction-associated steatohepatitis.Front Med (Lausanne)202642245952PubTator, text miningPubMed
The Framework of Precision Pharmacotherapy in Metabolic Dysfunction-Associated Steatohepatitis: A Network Meta-Analysis.Clin Pharmacol Ther202642233597PubTator, text miningPubMed
Lingual thyroid and resistance to thyroid hormone beta due to a novel THRB c.1312 C > T mutation in a child: diagnostic pitfalls and management.Endocrine202642228305PubTator, text miningPubMed
Repurposing Resmetirom to Suppress MASLD/MASH-HCC in the Dysmetabolic Era.Oncol Ther202642141212PubTator, text miningPubMed

gene-search-2026-11-11-0.2.0

Previous pageNext page

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/7068/papers?page=2

API referenceFor AI assistants